Visceral Adipose Predicts Prognosis and Toxicities in Locally Advanced Bladder Cancer Patients Treated With Adjuvant Gemcitabine Plus Cisplatin Chemotherapy
This study demonstrated that, among patients treated with adjuvant chemotherapy for locally advanced BC, patients in the low-VATI group exhibited a significantly prolonged PFS compared to those in the high-VATI group. However, no significant difference was observed in terms of OS. Regarding chemotherapy-related AEs, patients in the high-VATI group exhibited a relatively lower incidence and severity of toxic reactions.
Authors
- Lei Zhang (ORCID: https://orcid.org/0000-0001-5208-8890)
- Nienie Qi (ORCID: https://orcid.org/0000-0002-0123-7224)
- Zhen Li (ORCID: https://orcid.org/0000-0001-8037-4245)
- Junqi Wang (ORCID: https://orcid.org/0000-0001-5192-7234)
- Zhimin Gao (ORCID: https://orcid.org/0000-0001-6394-287X)
- Xu Qin (ORCID: https://orcid.org/0000-0002-0655-5547)
- Hailong Li (ORCID: https://orcid.org/0009-0007-9767-0877)
- Zewei Wang (ORCID: https://orcid.org/0009-0002-0378-1474)
Institutions
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1002/cam4.70742
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Six Talent Peaks Project in Jiangsu Province